ROBERT CASQUEJO: Open Payments
NPI 1043317050 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$103,155 in 346 payments from 24 companies in 2025. Trend: 2023 $123,831 · 2024 $119,996 · 2025 $103,155
Speaker / faculty: $53,040Travel & lodging: $21,844Consulting: $18,745Food & beverage: $9,232Education: $294
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 63 | $35,358 |
| Lilly USA, LLC | 67 | $26,853 |
| Arcutis Biotherapeutics, Inc. | 39 | $16,506 |
| ABBVIE INC. | 35 | $9,219 |
| Novartis Pharmaceuticals Corporation | 15 | $5,373 |
| Eli Lilly and Company | 6 | $4,217 |
| LEO Pharma Inc. | 16 | $1,134 |
| UCB, Inc. | 7 | $1,060 |
| Almirall LLC | 1 | $488 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $454 |
Products named: Otezla, Zoryve, SKYRIZI, EBGLYSS, Bimzelx, ADBRY, Seysara, DUPIXENT.
Industry payments across AZ — which companies pay providers there.
